Oral Versus Intravenous Antibiotics for the Management of the Osteomyelitis of the Jaws: An Open-Label Non-Inferiority Single-Arm Clinical Trial
Latest Information Update: 23 Jul 2024
At a glance
- Drugs Amoxicillin/clavulanic acid (Primary) ; Ampicillin/sulbactam (Primary) ; Clindamycin (Primary) ; Clindamycin (Primary) ; Levofloxacin (Primary)
- Indications Osteomyelitis
- Focus Therapeutic Use
- 17 Jul 2024 Planned initiation date changed from 1 Mar 2024 to 31 Jul 2024.
- 16 Jan 2024 Planned initiation date changed from 1 Nov 2023 to 1 Mar 2024.
- 17 Oct 2023 Status changed from recruiting to not yet recruiting.